This is a guest post by Oleksandr Topachevskyi at Digital Health Outcomes. Oleksandr may be contacted at sales@digitalho.com Commercial, nonprofit, and government companies are quite good at calculating the costs…
The post Social Return on Investment a…
This is a guest post by Ray Miller and Megan E. Bowers, Ph.D. at DLA Piper. Ray may be contacted at raymond.miller@dlapiper.com. When it comes to protecting therapeutic assets, I…
The post The value of method of use patent claims in protecting your the…
The value of method of use patent claims in protecting your therapeutic assets Read Post »
This paper was originally published by Andreas H. Göller, Lara Kuhnke, Floriane Montanari, Anne Bonin, Sebastian Schneckener, Antoniuster Laak, Jörg Wichard, Mario Lobell, and Alexander Hillisch in Drug Discovery Today…
The post Bayer’s in silico ADMET…
This paper was originally published by Md. Imtiaz Hasan et al in Journal of Biosciences and Medicines under a Creative Commons Attribution 4.0 International License Abstract Development of generic drug product…
The post Development of Generic Drug Prod…
This article was originally published by Sajna T. in Management Insight, 16(1):38-40 under a creative commons license. Abstract Business enterprises are an important organ of society. The impact of a…
The post Indian Pharma—Some Challenges and Acceptan…
This is a guest post by Shamil Gizatullin, Gowling WLG (International) Inc. shamil.gizatullin@gowlingwlg.com Although it has become harder to obtain patent-term extensions for drugs, pesticides or agricultural chemicals, a careful…
The post Getting the…
Getting the most out of pharmaceutical patent-term extensions in Russia Read Post »
By Joshua Mansour, M.D. Patients should have as much access to information as possible. The more they know, the more
Are Headlines of Medical Breakthroughs Overstating Actual Science and Research? Read Post »
By Joshua Mansour, M.D. The head of the National Cancer Institute, Dr. Norman “Ned” Sharpless, will be temporarily appointed as acting
New FDA Commissioner: What this means for Cancer Testing and Treatment Read Post »
By Joshua Mansour, M.D. From the beginning of medical school, one of the first things “instructional videos” that we had
By Nanette Moss, S.M., C.I.H., Senior Scientist and Project Executive with Environmental Health & Engineering, Inc. What is business continuity planning and why it is important? Emergencies may be infrequent…
The post Business Continuity and Resiliency…
Business Continuity and Resiliency Planning for Biomedical and Research Organizations Read Post »